| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5987311 | The Journal of Heart and Lung Transplantation | 2014 | 9 Pages |
Abstract
Serum hemolysis marker elevations are associated with increased events in LVAD patients. LDH monitoring provides an earlier diagnosis of adverse events than sfHg, supporting need for a new INTERMACS definition of VAD-associated hemolysis.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jennifer A. MD, Matthew A. MD, Palak MD, MS, Neha MBBS, CCRP, Vivek BS, Jonathan W. MD, Keith D. MD, MS, Francis D. MD, PhD,